Inhibitor of κ-light polypeptide gene enhancer in B cells, kinase-β (IKBKβ; IKKβ); IL-1 receptor–associated kinase 4 (IRAK4); NF-κB BriefCommunication Pages: 1689 - 1689
CUG triplet repeat, RNA binding protein 1 (CUGBP1); protein kinase C (PKC) BriefCommunication Pages: 1691 - 1691
ELOVL family member 6 elongation of long-chain fatty acids (ELOVL6; FAE) BriefCommunication Pages: 1693 - 1693
EPH receptor B2 (EPHB2); ABL tyrosine kinase (ABL; ABL1; c-ABL) BriefCommunication Pages: 1694 - 1694
Fc γ-receptor IIa (CD32A; FCGR2A); solute carrier family 26 member 3 (SLC26A3) BriefCommunication Pages: 1695 - 1695
Sp7 transcription factor (OSX); myc-associated protein with JmjC domain (NO66) BriefCommunication Pages: 1700 - 1700
Survival of motor neuron 1 telomeric (SMN1; SMN); survival of motor neuron 2 centromeric (SMN2; SMNC) BriefCommunication Pages: 1701 - 1701
Detection of oncogenic alternative telomere lengthening in cancer BriefCommunication Pages: 1707 - 1707
Proteomics-based identification of potential lymphoma drug targets BriefCommunication Pages: 1708 - 1708
Optimal blood sampling for detecting acute myelogenous leukemia (AML) relapse BriefCommunication Pages: 1709 - 1709
Kinase suppressor of ras 2 (KSR2)-deficient mice as obesity models BriefCommunication Pages: 1710 - 1710
In vivo quantification of myelin with positron-emitting carbon-11–labeled Case Imaging Compound positron emission tomography ([11C]CIC-PET) BriefCommunication Pages: 1715 - 1715
Nuclear magnetic resonance (NMR)-based monitoring of chemotherapy progress with [13C]metabolites BriefCommunication Pages: 1716 - 1716